Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99
Last updated 2024-05-08
Summary
This study aims to evaluate the efficacy of IL-37 as a biomarker to predict mortality risk in adults with sepsis.
Conditions
Sponsors & Collaborators
-
Zhongnan Hospital
lead OTHER
Principal Investigators
-
Dawei Wang, MD · Wuhan University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-03-23
- Primary Completion
- 2024-03-20
- Completion
- 2024-03-20
Countries
- China
Study Locations
More Related Trials
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
The Role of NLR in the Diagnosis and Prognosis of Sepsis
NCT05636202 ·Status: COMPLETED
-
A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 ·Status: UNKNOWN
-
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
NCT02887274 ·Status: UNKNOWN
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Early Prediction of Sepsis by Using Metabolomics
NCT03996759 ·Status: UNKNOWN
-
Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
NCT02654561 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison the Value of Several Biomarkers of Sepsis
NCT01388725 ·Status: COMPLETED
-
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400 ·Status: UNKNOWN
-
Co-inhibitory Molecules on Treg and miR-155-5p in Patients With Sepsis
NCT05126537 ·Status: UNKNOWN
-
Dissecting How Peripheral Lymphocytes Are Lost During Sepsis
NCT03289312 ·Status: UNKNOWN
-
Immune Function Monitoring and Immunotherapy in Sepsis
NCT04903405 ·Status: UNKNOWN
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
Correlation of Formyl Peptide Receptor 1 With Sepsis-related Encephalopathy
NCT05451537 ·Status: UNKNOWN
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
Evaluation of the Prognostic Value of Immature Platelet Fraction
NCT07039227 ·Status: COMPLETED
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
INFLAmmasomes NLRP3 in Platelets and Leukocytes During SEPSIS in Intensive Care Unit
NCT04635878 ·Status: COMPLETED
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
Value of Laboratory Biomarkers in Prediction of Outcome in Septic Patients
NCT06338124 ·Status: RECRUITING
-
Hepcidin: a Prognostic Marker of Morbidity and Mortality in Severe Sepsis?
NCT03682003 ·Status: UNKNOWN
-
Myeloid-derived Suppressor Cells in Sepsis
NCT03540797 ·Status: UNKNOWN
-
A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children
NCT05142813 ·Status: UNKNOWN
-
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
NCT06446947 ·Status: RECRUITING
-
Study of Biomarkers in Patients of Sepsis Complicated With Gastrointestinal Dysfunction
NCT04647201 ·Status: UNKNOWN